Figure 2.
Changes of serum CD26/DPPIV levels following YS110 treatment: soluble CD26 (A) and DPPIV activity (B) mean±s.d. at cycle 1 at the different dose levels.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.